SARS-CoV-2 variants from mink evade inhibition by antibodies

It has been known for about a year that minks can become infected with SARS-CoV-2. The virus had been transmitted from humans to farmed mink and mutated in infected animals. Mutations were acquired in the spike protein, which is crucial for the entry of the virus into host cells and represents the central point of attack for antibodies. These SARS-CoV-2 variants from mink were transmitted back to humans, raising concerns that minks could be a continuing source of infection of humans with SARS-CoV-2 variants with altered biological properties. Researchers at the German Primate Center (DPZ) - Leibniz Institute for Primate Research in Göttingen, Germany, have now shown that an antibody used for COVID-19 therapy is unable to effectively inhibit SARS-CoV-2 harboring a spike mutation acquired in minks. In addition, the mutation reduced the inhibition of the virus by antibodies produced in SARS-CoV-2 infected humans. These results show that SARS-CoV-2 can acquire mutations in minks that may reduce control of the virus by the human immune system. The study and findings have been published in Cell Reports.

SARS-CoV-2 escape mutations identified against monoclonal antibodies and polyclonal immune sera

Deutsches Primatenzentrum: SARS-CoV-2 variants from mink evade inhibition by antibodies

Broad immunity to SARS-CoV-2 variants of concern mediated by a SARS-CoV-2 receptor-binding domain protein vaccine - eBioMedicine

Broadly Effective ACE2 Decoy Proteins Protect Mice from Lethal SARS-CoV-2 Infection

Convalescent-Phase Sera and Vaccine-Elicited Antibodies Largely Maintain Neutralizing Titer against Global SARS-CoV-2 Variant Spikes

Pharmacological activation of STING blocks SARS-CoV-2 infection

SARS-CoV-2 Variants and Vaccination – ScienceOpen

Towards the development of a SARS-CoV-2 variant risk assessment tool: expert consultation on the assessment of scientific evidence on emerging variants - The Lancet Microbe

Full article: Potent immunogenicity and broad-spectrum protection potential of microneedle array patch-based COVID-19 DNA vaccine candidates encoding dimeric RBD chimera of SARS-CoV and SARS-CoV-2 variants

Mechanisms of COVID-19 pathogenesis in diabetes American Journal of Physiology-Heart and Circulatory Physiology

Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants

SARS-CoV-2 variant biology: immune escape, transmission and fitness

Antibodies, Free Full-Text

Evasion of vaccine-induced humoral immunity by emerging sub-variants of SARS -CoV-2

SARS-CoV-2 Variants From Mink Evade Inhibition by Antibody